A pharmaceutical firm had a potential BD&L opportunity that it was considering. To validate the value of this opportunity, it needed to understand the potential adoption of a product for the treatment of a women’s health condition among obstetricians and gynecologists, specifically in the EU.
The GLG Approach
Wanting to evaluate the current landscape, GLG fielded a quantitative survey to uncover patient demographic and current treatment decisions.
Once the current landscape was set, the team showed the target audience the specifications for a new treatment. Given the assumption that it would be approved for use and fully reimbursed, respondents were asked the likelihood of their prescribing the product and with what frequency.
The team showed the respondents a second set of specifications for two additional products and asked them about the likelihood and frequency of prescription, assuming all three products were available.
The data gave an indication of potential success of the new treatment in a future landscape where more treatment options would be available.
In a two-week time frame GLG provided the pharma client with a quantified report about the potential adoption of the product, which helped the client derive the value of the acquisition and make the strategic decision whether to proceed.
GLG used internal methodology expertise to design the study around the overarching aims of the project.
GLG utilised specialist physicians to hear from key decision makers regarding future prescription intention.
GLG gathered insights from 100 physicians across Europe.
Let us start helping you today.
As the world’s insight network, GLG connects clients to the subject-matter experts who can provide real-world insights to make informed decisions. Our team of professionals work with you to create a tailored approach that identifies, assesses, and answers your questions on your timeline. We bring the power of insight to every great professional decision.